应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02172 微创脑科学
未开盘 07-22 16:08:56
7.330
+0.150
+2.09%
最高
7.350
最低
7.160
成交量
31.00万
今开
7.250
昨收
7.180
日振幅
2.65%
总市值
42.71亿
流通市值
42.71亿
总股本
5.83亿
成交额
226.13万
换手率
0.05%
流通股本
5.83亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
港股异动 | 微创系全线走低 心脉医疗高价收购OMD引监管质疑 野村曾指长期债务问题依旧艰难
智通财经 · 07-19
港股异动 | 微创系全线走低 心脉医疗高价收购OMD引监管质疑 野村曾指长期债务问题依旧艰难
南向资金7月12日净买入微创脑科学24.80万股 连续3日增持
自选股智能写手 · 07-15
南向资金7月12日净买入微创脑科学24.80万股 连续3日增持
微创脑科学午后涨近8% 预计上半年收入同比增长约34%至37%
新浪港股 · 07-11
微创脑科学午后涨近8% 预计上半年收入同比增长约34%至37%
港股异动 | 微创脑科学(02172)再涨超12% 此前发盈喜 预计上半年收入增超三成
智通财经 · 07-11
港股异动 | 微创脑科学(02172)再涨超12% 此前发盈喜 预计上半年收入增超三成
【港股通】微创脑科学(02172)涨超12% 公司近日发盈喜 机构料医疗器械国产化率有望进一步提升
金吾财讯 · 07-11
【港股通】微创脑科学(02172)涨超12% 公司近日发盈喜 机构料医疗器械国产化率有望进一步提升
微创脑科学(02172)上涨7.78%,报6.93元/股
金融界 · 07-11
微创脑科学(02172)上涨7.78%,报6.93元/股
微创脑科学盘中异动 快速拉升5.75%报6.800港元
自选股智能写手 · 07-11
微创脑科学盘中异动 快速拉升5.75%报6.800港元
港股异动 | 微创脑科学(02172)回落逾5% 此前发盈喜预计上半年收入增超三成
智通财经 · 07-08
港股异动 | 微创脑科学(02172)回落逾5% 此前发盈喜预计上半年收入增超三成
微创脑科学(02172)下跌5.01%,报6.64元/股
金融界 · 07-08
微创脑科学(02172)下跌5.01%,报6.64元/股
微创脑科学盘中异动 早盘急速下跌5.01%
自选股智能写手 · 07-08
微创脑科学盘中异动 早盘急速下跌5.01%
微创脑科学授出44.5万份购股权
新浪港股 · 07-08
微创脑科学授出44.5万份购股权
微创脑科学(02172)授出44.5万份购股权
智通财经 · 07-05
微创脑科学(02172)授出44.5万份购股权
微创脑科学(02172)下跌5.01%,报6.83元/股
金融界 · 07-04
微创脑科学(02172)下跌5.01%,报6.83元/股
微创脑科学盘中异动 临近午盘股价大跌5.02%报6.830港元
自选股智能写手 · 07-04
微创脑科学盘中异动 临近午盘股价大跌5.02%报6.830港元
微创脑科学(02172)股价下跌5.007%,现价港币$6.83
阿斯达克财经 · 07-04
微创脑科学(02172)股价下跌5.007%,现价港币$6.83
南向资金7月3日净买入微创脑科学19.00万股 连续3日增持
自选股智能写手 · 07-04
南向资金7月3日净买入微创脑科学19.00万股 连续3日增持
微创脑科学(02172.HK)曾升近25% 料上半年收入增长34%至37%
阿斯达克财经 · 07-03
微创脑科学(02172.HK)曾升近25% 料上半年收入增长34%至37%
微创脑科学早盘涨超13% 预计中期收入同比增长约34%至37%
金融界 · 07-03
微创脑科学早盘涨超13% 预计中期收入同比增长约34%至37%
【盈喜股】微创脑科学(02172)涨近13% 料中期收入同比增长约34%-37%
金吾财讯 · 07-03
【盈喜股】微创脑科学(02172)涨近13% 料中期收入同比增长约34%-37%
港股异动 | 微创脑科学(02172)盈喜后涨超14% 预计中期收入同比增长超三成
智通财经 · 07-03
港股异动 | 微创脑科学(02172)盈喜后涨超14% 预计中期收入同比增长超三成
加载更多
公司概况
公司名称:
微创脑科学
所属市场:
SEHK
上市日期:
--
主营业务:
微创脑科学有限公司是一家中国的投资控股公司。该公司主要从事神经介入医疗器械的研发、制造及销售。该公司的主要产品包括栓塞弹簧圈、血流导向密网支架及覆膜支架。该公司的产品主要涵盖神经血管疾病的三大领域,即出血性脑卒中、脑动脉粥样硬化狭窄及急性缺血性脑卒中。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02172","market":"HK","secType":"STK","nameCN":"微创脑科学","latestPrice":7.33,"timestamp":1721635736030,"preClose":7.18,"halted":0,"volume":310000,"delay":0,"floatShares":582658100,"shares":582658100,"eps":0.26735476,"marketStatus":"未开盘","marketStatusCode":0,"change":0.15,"latestTime":"07-22 16:08:56","open":7.25,"high":7.35,"low":7.16,"amount":2261260,"amplitude":0.026462,"askPrice":7.33,"askSize":29000,"bidPrice":7.3,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":0.2673547680392249,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"listingDate":1657814400000,"adjPreClose":7.18,"dividendRate":0.014603,"openAndCloseTimeList":[[1721611800000,1721620800000],[1721624400000,1721635200000]],"volumeRatio":0.512905,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02172","defaultTab":"news","newsList":[{"id":"2452412392","title":"港股异动 | 微创系全线走低 心脉医疗高价收购OMD引监管质疑 野村曾指长期债务问题依旧艰难","url":"https://stock-news.laohu8.com/highlight/detail?id=2452412392","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452412392?lang=zh_cn&edition=full","pubTime":"2024-07-19 14:36","pubTimestamp":1721370989,"startTime":"0","endTime":"0","summary":"消息面上,7月2日,心脉医疗发布公告称,公司全资子公司荷兰心脉拟使用自有资金6500万美元收购OMD公司72.37%股权。对此,监管就交易估值对价合理性及交易方是否存在潜在利益等一系列问题发出质疑。据微创医疗2023年年报,企业现金流已现吃紧迹象。野村此前研报指出,公司短期内情况或有好转,长期债务问题依旧艰难。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153073.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","YANG","HSCEI","00853","BK0251","688016","BK1585","BK1589","02252","02172","BK1100","HSTECH"],"gpt_icon":1},{"id":"2451650731","title":"南向资金7月12日净买入微创脑科学24.80万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2451650731","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451650731?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:31","pubTimestamp":1721007095,"startTime":"0","endTime":"0","summary":"7月12日, 南向资金增持微创脑科学24.80万股,连续3日增持。截止当日收盘,港股通共持有微创脑科学2307.10万股,占流通股3.95%。港股通增持金额前五个股分别为建设银行、中国移动、中国联通、碧桂园服务、名创优品。微创脑科学近5个交易日上涨4.15%,港股通累计增持25.70万股;近20个交易日下跌2.93%,港股通累计增持217.70万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407150943369f4bb55f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407150943369f4bb55f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02172","BK1100"],"gpt_icon":0},{"id":"2450780743","title":"微创脑科学午后涨近8% 预计上半年收入同比增长约34%至37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450780743","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450780743?lang=zh_cn&edition=full","pubTime":"2024-07-11 13:26","pubTimestamp":1720675560,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 微创脑科学(02172)午后上涨7.62%,现报6.92港元,成交额1264.92万港元。\n 微创脑科学公布,预期截至6月底六个月收入约为人民币4亿元至人民币4.10亿元之间,同比增长约34%至37%。\n 公告称,收入预期增幅主要归因于海外业务实现突破性进展,报告期内收入预期同比提升约70%至90%;颅内动脉粥样硬化狭窄产品持续提升市场份额,实现收入显著增长等。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-11/doc-incctvax8581501.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-11/doc-incctvax8581501.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","02172"],"gpt_icon":0},{"id":"2450805441","title":"港股异动 | 微创脑科学(02172)再涨超12% 此前发盈喜 预计上半年收入增超三成","url":"https://stock-news.laohu8.com/highlight/detail?id=2450805441","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450805441?lang=zh_cn&edition=full","pubTime":"2024-07-11 11:15","pubTimestamp":1720667711,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,微创脑科学(02172)再涨超12%,截至发稿,涨8.09%,报6.95港元,成交额1200.1万港元。消息面上,微创脑科学公布,预期截至6月底六个月收入约为人民币4亿元至人民币4.10亿元之间,同比增长约34%至37%。公告称,收入预期增幅主要归因于海外业务实现突破性进展,报告期内收入预期同比提升约70%至90%;颅内动脉粥样硬化狭窄产品持续提升市场份额,实现收入显著增长等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1149184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02172","YANG","HSTECH","BK1100","HSCEI","07226"],"gpt_icon":0},{"id":"2450802808","title":"【港股通】微创脑科学(02172)涨超12% 公司近日发盈喜 机构料医疗器械国产化率有望进一步提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2450802808","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450802808?lang=zh_cn&edition=full","pubTime":"2024-07-11 10:45","pubTimestamp":1720665920,"startTime":"0","endTime":"0","summary":"金吾财讯 | 微创脑科学 盘中涨超12%,截至发稿,涨11.35%,报7.16港元,成交额1018万港元。方正证券此前表示,在贴息采购等多维政策支持下,医疗器械各细分赛道国产化率显著提升,其中,监护仪、DR、冠脉支架等超70%,而DSA、透析、电生理、人工晶体等不足30%。随着医疗建设需求释放、集采等政策推进、创新产品持续推出,高端、创新医疗器械国产化率有望进一步提升。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/ZTU4MTQyOTUwMTU0Mjk=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZTU4MTQyOTUwMTU0Mjk=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1940195","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","09996","BK1100","07226","HSCEI","HSTECH","09997","159883","02172","BK1222","YANG","BK1583"],"gpt_icon":0},{"id":"2450871453","title":"微创脑科学(02172)上涨7.78%,报6.93元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450871453","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450871453?lang=zh_cn&edition=full","pubTime":"2024-07-11 09:43","pubTimestamp":1720662223,"startTime":"0","endTime":"0","summary":"7月11日,微创脑科学(02172)盘中上涨7.78%,截至09:43,报6.93元/股,成交128.32万元。微创脑科学有限公司是中国神经介入医疗器械行业的领军企业,主要提供创新的医疗解决方案。自2004年以来,公司已经成功研发并商业化了30款产品。截至2023年年报,微创脑科学营业总收入6.66亿元、净利润1.46亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/11094341504304.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02172","BK1100"],"gpt_icon":0},{"id":"2450874253","title":"微创脑科学盘中异动 快速拉升5.75%报6.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450874253","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450874253?lang=zh_cn&edition=full","pubTime":"2024-07-11 09:43","pubTimestamp":1720662216,"startTime":"0","endTime":"0","summary":"截至发稿,该股报6.800港元/股,成交量17.7万股,换手率0.03%,振幅2.80%。微创脑科学股票所在的医疗设备及用品行业中,整体涨幅为0.00%。其相关个股中,微创脑科学、加和国际控股、心泰医疗涨幅较大,振幅较大的相关个股有加和国际控股、智云健康、威高股份,振幅分别为6.56%、3.98%、2.33%。消息层面,截至09时43分,微创脑科学股票正面舆情新闻比例83.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711094337aef916a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711094337aef916a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","02172"],"gpt_icon":0},{"id":"2449671225","title":"港股异动 | 微创脑科学(02172)回落逾5% 此前发盈喜预计上半年收入增超三成","url":"https://stock-news.laohu8.com/highlight/detail?id=2449671225","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449671225?lang=zh_cn&edition=full","pubTime":"2024-07-08 11:54","pubTimestamp":1720410892,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,微创脑科学回落逾5%,截至发稿,跌3.58%,报6.74港元,成交额455.32万港元。消息面上,微创脑科学公布,预期截至6月底六个月收入约为人民币4亿元至人民币4.10亿元之间,同比增长约34%至37%。根据协议,微创医疗需要在3年内扭亏。财报显示,该公司2023年实现收入9.51亿美元,同比增长15.8%;公司权益股东应占亏损4.78亿美元,同比扩大9.4%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1146758.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02172","BK1100","HSTECH","HSCEI","07226","YANG"],"gpt_icon":0},{"id":"2449718113","title":"微创脑科学(02172)下跌5.01%,报6.64元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449718113","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449718113?lang=zh_cn&edition=full","pubTime":"2024-07-08 09:45","pubTimestamp":1720403130,"startTime":"0","endTime":"0","summary":"7月8日,微创脑科学(02172)盘中下跌5.01%,截至09:45,报6.64元/股,成交158.83万元。微创脑科学有限公司是中国神经介入医疗器械行业的领军企业,主要提供创新的医疗解决方案。自2004年以来,公司已经成功研发并商业化了30款产品。截至2023年年报,微创脑科学营业总收入6.66亿元、净利润1.46亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/08094541424967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1100","02172"],"gpt_icon":0},{"id":"2449718296","title":"微创脑科学盘中异动 早盘急速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449718296","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449718296?lang=zh_cn&edition=full","pubTime":"2024-07-08 09:45","pubTimestamp":1720403129,"startTime":"0","endTime":"0","summary":"2024年07月08日早盘09时45分,微创脑科学股票出现波动,股价急速下挫5.01%。截至发稿,该股报6.640港元/股,成交量23.5万股,换手率0.04%,振幅4.15%。微创脑科学股票所在的医疗设备及用品行业中,整体涨幅为0.01%。微创脑科学公司简介:微创脑科学有限公司是一家中国的投资控股公司。该公司主要在中国国内和海外市场开展业务。消息层面,截至09时45分,微创脑科学股票正面舆情新闻比例100%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708094529941f4a25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708094529941f4a25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02172","BK1100"],"gpt_icon":0},{"id":"2449453799","title":"微创脑科学授出44.5万份购股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2449453799","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449453799?lang=zh_cn&edition=full","pubTime":"2024-07-08 07:43","pubTimestamp":1720395825,"startTime":"0","endTime":"0","summary":"微创脑科学(02172)发布公告,于2024年7月5日,公司已决议根据公司于2023年7月12日采纳的股份计划向55名合资格参与者授出购股权,以合共认购最多44.5万股公司股本中每股面值0.00002美元的公司普通股,但须待承授人接纳后,方可作实。购股权的行使价为每股6.990港元。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-07-08/doc-inccknzr9710774.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-07-08/doc-inccknzr9710774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["02172","BK1100"],"gpt_icon":0},{"id":"2449159296","title":"微创脑科学(02172)授出44.5万份购股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2449159296","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449159296?lang=zh_cn&edition=full","pubTime":"2024-07-05 22:51","pubTimestamp":1720191092,"startTime":"0","endTime":"0","summary":"智通财经APP讯,微创脑科学(02172)发布公告,于2024年7月5日,公司已决议根据公司于2023年7月12日采纳的股份计划向55名合资格参与者授出购股权,以合共认购最多44.5万股公司股本中每股面值0.00002美元的公司普通股,但须待承授人接纳后,方可作实。购股权的行使价为每股6.990港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1146525.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","02172"],"gpt_icon":0},{"id":"2448498987","title":"微创脑科学(02172)下跌5.01%,报6.83元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448498987","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448498987?lang=zh_cn&edition=full","pubTime":"2024-07-04 11:39","pubTimestamp":1720064349,"startTime":"0","endTime":"0","summary":"7月4日,微创脑科学(02172)盘中下跌5.01%,截至11:39,报6.83元/股,成交866.03万元。微创脑科学有限公司是中国神经介入医疗器械行业的领军企业,主要提供创新的医疗解决方案。自2004年以来,公司已经成功研发并商业化了30款产品。截至2023年年报,微创脑科学营业总收入6.66亿元、净利润1.46亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/04113941367941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1100","02172"],"gpt_icon":0},{"id":"2448003460","title":"微创脑科学盘中异动 临近午盘股价大跌5.02%报6.830港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448003460","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448003460?lang=zh_cn&edition=full","pubTime":"2024-07-04 11:39","pubTimestamp":1720064343,"startTime":"0","endTime":"0","summary":"2024年07月04日临近午盘11时39分,微创脑科学股票出现异动,股价大幅下挫5.02%。截至发稿,该股报6.830港元/股,成交量122.2万股,换手率0.21%,振幅7.65%。资金方面,该股资金流入271.743万港元,流出410.49万港元。微创脑科学股票所在的医疗设备及用品行业中,整体跌幅为0.03%。其相关个股中,加和国际控股、先瑞达医疗-B、业聚医疗涨幅较大,振幅较大的相关个股有微创脑科学、智云健康、先瑞达医疗-B,振幅分别为7.65%、6.42%、6.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704113903941f3c13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704113903941f3c13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","02172"],"gpt_icon":0},{"id":"2448408498","title":"微创脑科学(02172)股价下跌5.007%,现价港币$6.83","url":"https://stock-news.laohu8.com/highlight/detail?id=2448408498","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448408498?lang=zh_cn&edition=full","pubTime":"2024-07-04 11:39","pubTimestamp":1720064340,"startTime":"0","endTime":"0","summary":"[下跌股]微创脑科学(02172) 股价在上午11:38比前收市价下跌5.007%,现股价为港币$6.83。至目前为止,今日最高价为$7.38,而最低价为$6.83。总成交量为121.6万股,总成交金额为港币$861.937万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240704819/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1100","02172"],"gpt_icon":0},{"id":"2448465938","title":"南向资金7月3日净买入微创脑科学19.00万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2448465938","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448465938?lang=zh_cn&edition=full","pubTime":"2024-07-04 09:31","pubTimestamp":1720056694,"startTime":"0","endTime":"0","summary":"7月3日, 南向资金增持微创脑科学19.00万股,连续3日增持。截止当日收盘,港股通共持有微创脑科学2149.10万股,占流通股3.68%。港股通增持金额前五个股分别为中国移动、工商银行、建设银行、招商银行、中国石油股份。微创脑科学近5个交易日上涨10.62%,港股通累计减持54.10万股;近20个交易日下跌21.76%,港股通累计增持194.60万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407040941379effcd67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407040941379effcd67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","02172"],"gpt_icon":0},{"id":"2448795144","title":"微创脑科学(02172.HK)曾升近25% 料上半年收入增长34%至37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448795144","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448795144?lang=zh_cn&edition=full","pubTime":"2024-07-03 11:35","pubTimestamp":1719977700,"startTime":"0","endTime":"0","summary":"微创脑科学(02172.HK) 发盈喜,今日高开9.03%,早段最高见8元,一度升24.6%。现报7.2元,升12.15%,成交415.8万股,涉资3,108.69万元。公司预计,截至6月30日止六个月收入约为4亿元至4.1亿人民币元之间,按年增长约34%至37%,期内海外业务实现突破性进展,颅内动脉粥样硬化狭窄产品持续提升市场份额。(cy/a)(港股报价延迟最少十五分钟。沽空资料截至 2024-07-02 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220719121248851_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220719121248851_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1361042/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02172","BK1100"],"gpt_icon":0},{"id":"2448110700","title":"微创脑科学早盘涨超13% 预计中期收入同比增长约34%至37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448110700","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448110700?lang=zh_cn&edition=full","pubTime":"2024-07-03 09:45","pubTimestamp":1719971146,"startTime":"0","endTime":"0","summary":"微创脑科学发盈喜后股价上涨13.08%,现报7.26港元,成交额670.38万港元。微创脑科学公布,于截至2024年6月30日止六个月内,预期集团将取得收入约为人民币4亿元至人民币4.10亿元之间,同比增长约34%至37%。\n\n\r\n 责任编辑:栎树","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/03094541341407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02172","BK1100"],"gpt_icon":0},{"id":"2448110596","title":"【盈喜股】微创脑科学(02172)涨近13% 料中期收入同比增长约34%-37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448110596","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448110596?lang=zh_cn&edition=full","pubTime":"2024-07-03 09:40","pubTimestamp":1719970847,"startTime":"0","endTime":"0","summary":"金吾财讯 | 微创脑科学(02172)股价高开高走,截至发稿,涨近13%,报7.24港元,成交额328万港元。消息面上,公司发盈喜,于截至2024年6月30日止六个月内,预期集团将取得收入约为人民币4亿元至人民币4.10亿元之间,较截至2023年6月30日止六个月增长约34%至37%。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/NTRmYzVmNDdmYzg0MjRhYWE5NzljZDI3ZDUxMDYzNjE2NzY4MDQ=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NTRmYzVmNDdmYzg0MjRhYWE5NzljZDI3ZDUxMDYzNjE2NzY4MDQ=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1939648","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02172"],"gpt_icon":0},{"id":"2448110996","title":"港股异动 | 微创脑科学(02172)盈喜后涨超14% 预计中期收入同比增长超三成","url":"https://stock-news.laohu8.com/highlight/detail?id=2448110996","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448110996?lang=zh_cn&edition=full","pubTime":"2024-07-03 09:33","pubTimestamp":1719970385,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,微创脑科学(02172)盈喜后涨超14%,截至发稿,涨14.64%,报7.36港元,成交额227.79万港元。消息面上,微创脑科学公布,于截至2024年6月30日止六个月内,预期集团将取得收入约为人民币4亿元至人民币4.10亿元之间,同比增长约34%至37%。收入预期增幅主要归因于海外业务实现突破性进展,报告期内收入预期同比提升约70%至90%;颅内动脉粥样硬化狭窄产品(包括Bridge®椎动脉雷帕霉素靶向洗脱支架系统、APOLLO™颅内动脉支架系统等)持续提升市场份额,实现收入显著增长等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1144842.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSCEI","BK1100","YANG","HSTECH","07226","02172"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.medneurotech.com","stockEarnings":[{"period":"1week","weight":0.0427},{"period":"1month","weight":0.0573},{"period":"3month","weight":-0.1333},{"period":"6month","weight":-0.2146},{"period":"1year","weight":-0.4379},{"period":"ytd","weight":-0.391}],"compareEarnings":[{"period":"1week","weight":-0.0211},{"period":"1month","weight":-0.0218},{"period":"3month","weight":0.048},{"period":"6month","weight":0.1092},{"period":"1year","weight":-0.0755},{"period":"ytd","weight":0.0345}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"微创脑科学有限公司是一家中国的投资控股公司。该公司主要从事神经介入医疗器械的研发、制造及销售。该公司的主要产品包括栓塞弹簧圈、血流导向密网支架及覆膜支架。该公司的产品主要涵盖神经血管疾病的三大领域,即出血性脑卒中、脑动脉粥样硬化狭窄及急性缺血性脑卒中。该公司主要在中国国内和海外市场开展业务。","exchange":"SEHK","name":"微创脑科学","nameEN":"MICROPORT NEURO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"微创脑科学(02172)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供微创脑科学(02172)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"微创脑科学,02172,微创脑科学股票,微创脑科学股票老虎,微创脑科学股票老虎国际,微创脑科学行情,微创脑科学股票行情,微创脑科学股价,微创脑科学股市,微创脑科学股票价格,微创脑科学股票交易,微创脑科学股票购买,微创脑科学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"微创脑科学(02172)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供微创脑科学(02172)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}